Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M.

Slides:



Advertisements
Similar presentations
Martin B. Leon, M.D., Craig R. Smith, M.D., Michael Mack, M.D., D. Craig Miller, M.D., Jeffrey W. Moses, M.D., Lars G. Svensson, M.D., Ph.D., E. Murat.
Advertisements

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Volume 385, Issue 9986, Pages (June 2015)
Volume 387, Issue 10034, Pages (May 2016)
One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End- Stage Renal Disease  Daniel P. O’Hair, MD, Tanvir K. Bajwa, MD, Stanley.
A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement  Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,
Ten-year trends in heart valve replacement operations
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States 
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis 
Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey  Joseph E. Bavaria, MD,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Reply The Annals of Thoracic Surgery
A comprehensive review of the PARTNER trial
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting  John V. Conte, MD, Thomas G. Gleason, MD, Jon.
Improved Mitral Valve Performance After Transapical Aortic Valve Implantation  Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
John M. Fallon, MD, Joseph P. DeSimone, MD, J
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER.
Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
James R. Edgerton, MD, Morley A
The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement?  Jose F. Condado, MD, MS, Hanna A. Jensen, MD,
Ten-year trends in heart valve replacement operations
Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension  Ramdas G. Pai, MD, Padmini Varadarajan,
Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality  Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons.
Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement  Hyun-Chel Joo, MD,
Use of Transaortic, Transapical, and Transcarotid Transcatheter Aortic Valve Replacement in Inoperable Patients  Vinod H. Thourani, MD, Rebecca L. Gunter,
Sam Chitsaz, MD, Nicolas Jaussaud, MD, Edward Chau, MD, Kimberly S
2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry  Frederick L. Grover, MD, Sreekanth.
The “Double-Valve” Sign in Acute Type A Aortic Dissection
Pulmonary Function Tests Overestimate Chronic Pulmonary Disease in Patients With Severe Aortic Stenosis  Mitchell J. Magee, MD, Morley A. Herbert, PhD,
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
Vinod H. Thourani, MD, Hanna A
Transcatheter Aortic Valve Replacement: How I Teach It
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
Percutaneous Transcatheter Closure of the Aortic Valve
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral  Thomas G. Gleason, MD,
Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M
Redo Aortic Valve Replacement in Children
Vinod H. Thourani, MD, Hanna A
Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement  Rakesh M. Suri, MD, DPhil, Brian C. Gulack,
Daniel P. O’Hair, MD, Tanvir K. Bajwa, MD, Jeffrey J
The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States 
Kreton Mavromatis, MD, Vinod H
Transapical Aortic Valve Implantation in High-Risk Patients With Severe Aortic Valve Stenosis  Augusto D'Onofrio, MD, Melissa Fusari, MD, Nicola Abbiate,
Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass
Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve  Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD 
Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve  Marjan Jahangiri, FRCS, Jean Claude Laborde,
United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex  Lars G. Svensson, MD, PhD, Todd Dewey,
Commentary: When a choice is not an echo
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Transapical Arterial Cannulation for Salvage Cardiopulmonary Bypass in Transcatheter Aortic Valve Replacement  Derek R. Brinster, MD, Jay A. Patel, Harry.
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Wilson Y. Szeto, MD, Joseph E. Bavaria, MD, Frank W
Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups  William T. Brinkman, MD, William Hoffman, MD, Todd.
Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Presentation transcript:

Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M. Dewey, MD, Bruce Bowers, MD, Vinod H. Thourani, MD, Vasilis Babaliaros, MD, Craig R. Smith, MD, Martin B. Leon, MD, Lars G. Svensson, MD, PhD, E. Murat Tuzcu, MD, D. Craig Miller, MD, Paul S. Teirstein, MD, Jeffrey Tyner, MD, David L. Brown, MD, Gregory P. Fontana, MD, Raj R. Makkar, MD, Mathew R. Williams, MD, Isaac George, MD, Ajay J. Kirtane, MD, MS, Joseph E. Bavaria, MD, Michael J. Mack, MD  The Annals of Thoracic Surgery  Volume 96, Issue 6, Pages 2083-2089 (December 2013) DOI: 10.1016/j.athoracsur.2013.05.093 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier time-to-event curves for all-cause mortality. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier time-to-event curves for stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier time-to-event curves for the composite end point of all-cause mortality or stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 New York Heart Association functional status among survivors. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions